Vicinitas Therapeutics is developing small molecule drugs that stabilize key proteins, preventing them from going to a cell's built-in disposal system. The startup, which stems from a research partnership between Novartis and the University of California, Berkeley, has raised $65 million in Series A funding.
Currently, according to Tufts researchers, clinical trials in a variety of therapeutic areas experience patient dropout rates close to 20%, with the consent process being the number 1 factor contributing to this figure.
It is critical that the consent process be tailored to ensure that participants understand what's being asked of them and how their data will help further future disease treatment. The Solution: eConsent
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. This is your chance to save $100 with the Early Bird Rate.
At the INVEST PhamaTech conference last month, five startups shared their vision for how they are seeking to reinvent clinical trials as part of the Pitch Perfect contest.
Nursing graduates are entering the profession in a state of anxiety about staffing shortages, with 55% of them saying they do not plan to stick with the career until retirement, according to a new report. The two main sources of this anxiety are worries about inadequate onboarding processes and being overworked.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments